NO954702L - Aryldannende medikamenter - Google Patents
Aryldannende medikamenterInfo
- Publication number
- NO954702L NO954702L NO954702A NO954702A NO954702L NO 954702 L NO954702 L NO 954702L NO 954702 A NO954702 A NO 954702A NO 954702 A NO954702 A NO 954702A NO 954702 L NO954702 L NO 954702L
- Authority
- NO
- Norway
- Prior art keywords
- active compounds
- compounds include
- forming drugs
- aryl forming
- antivirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/06—Phenols the aromatic ring being substituted by nitro groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
- C07C205/20—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings
- C07C205/21—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C205/24—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring having three, and only three, nitro groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
- C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
- C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/58—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
- C07C211/52—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/39—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing halogen atoms bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/40—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitro or nitroso groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/45—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/46—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton having the sulfo groups bound to carbon atoms of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
- C07C63/70—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Forskjellige arylerende stoff som utviser aktivitet i : behandlingen av cancer og virusinfeksjoner er avdekket. De aktive forbindelser innbefatter en aromatisk ring i j som har i det minste en labil gruppe som avspaltes, og i i det minste en elektrofil gruppe. Foretrukne aktive j forbindelser innbefatter klorbenzensulfonsyrer og ; valgfritt halogenerte nitrobenzenforbindelser. I ' antivirus-sammenheng er de aktive forbindelser virkningsfulle mot HIV-infeksjoner.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939310520A GB9310520D0 (en) | 1993-05-21 | 1993-05-21 | Arylating agents |
GB9405292A GB9405292D0 (en) | 1993-05-21 | 1994-03-17 | Arylating agents |
PCT/GB1994/001126 WO1994027584A2 (en) | 1993-05-21 | 1994-05-23 | Arylating medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
NO954702D0 NO954702D0 (no) | 1995-11-21 |
NO954702L true NO954702L (no) | 1996-01-22 |
Family
ID=26302926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954702A NO954702L (no) | 1993-05-21 | 1995-11-21 | Aryldannende medikamenter |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0700287A1 (no) |
JP (1) | JPH08510468A (no) |
CN (1) | CN1124012A (no) |
AP (1) | AP9400647A0 (no) |
AU (1) | AU6729794A (no) |
BG (1) | BG100242A (no) |
BR (1) | BR9406548A (no) |
CA (1) | CA2163459A1 (no) |
CZ (1) | CZ307395A3 (no) |
DZ (1) | DZ1781A1 (no) |
FI (1) | FI955605A (no) |
HU (1) | HUT77764A (no) |
IL (1) | IL109712A0 (no) |
MA (1) | MA23202A1 (no) |
NO (1) | NO954702L (no) |
OA (1) | OA10196A (no) |
SK (1) | SK145795A3 (no) |
WO (1) | WO1994027584A2 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE198273T1 (de) * | 1994-03-17 | 2001-01-15 | Radopath Pharmaceuticals Inter | Wirkstof gegen viren und krebs |
GB2288333A (en) * | 1994-03-17 | 1995-10-18 | Radopath Ltd | Benzoic acid containing chloro and or nitro groups for cancer or viral therapy |
WO1996029067A1 (en) * | 1995-03-17 | 1996-09-26 | Radopath Limited | Anti-viral and anti-cancer agents |
US5985927A (en) * | 1995-03-30 | 1999-11-16 | Kreutz; Werner | Medicaments for the selective treatment of tumor tissues |
US5756548A (en) * | 1995-04-03 | 1998-05-26 | Centaur Pharmaceuticals, Inc. | Acetamidobenzamide compounds for neurodegenerative disorders |
GB9615619D0 (en) * | 1996-03-18 | 1996-09-04 | Radopath Ltd | Costimulation of TcR/CD3-induced T-Lymphocytes |
US5955506A (en) * | 1996-04-03 | 1999-09-21 | Centaur Pharmaceuticals, Inc. | Benzamides for neurodegenerative disorder treatment |
EP1906948A4 (en) * | 2005-07-18 | 2010-03-17 | Bipar Sciences Inc | TREATMENT OF CANCER |
CA2662517A1 (en) | 2006-09-05 | 2008-03-13 | Jerome Moore | Treatment of cancer |
US7732491B2 (en) * | 2007-11-12 | 2010-06-08 | Bipar Sciences, Inc. | Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1283331A (en) * | 1970-01-03 | 1972-07-26 | Smith Kline French Lab | Pharmaceutical compositions |
US3978119A (en) * | 1975-07-11 | 1976-08-31 | Gulf Research & Development Company | Process for converting stilbene or bibenzyl to nitrobenzoic acids |
US4283421A (en) * | 1979-12-19 | 1981-08-11 | Ray Frank F | Anti-viral treatment |
US4277492A (en) * | 1980-05-21 | 1981-07-07 | The Dow Chemical Company | Novel 4-bis((Phenylmethyl)amino)-benzenesulfonic acids possessing antiviral activity |
US4762705A (en) * | 1981-11-10 | 1988-08-09 | Adolf W. Schwimmer | Cancer therapy with interferon |
US4935450A (en) * | 1982-09-17 | 1990-06-19 | Therapeutical Systems Corporation | Cancer therapy system for effecting oncolysis of malignant neoplasms |
CA1262864A (en) * | 1982-09-17 | 1989-11-14 | Clarence D. Cone | Method for producing oncolysis |
JPS60224619A (ja) * | 1984-04-24 | 1985-11-09 | Adeka Argus Chem Co Ltd | 放射線増感剤 |
RO92333B1 (ro) * | 1985-06-18 | 1987-09-01 | Institutul De Cercetari Chimico-Farmaceutice | Produs radiosensibilizator al celulelor tumorale |
JPS6468315A (en) * | 1987-09-09 | 1989-03-14 | Yasuo Kawasaki | Antipyrotic of picric acid (2,4,6-trinitrophenol) |
AU646840B2 (en) * | 1990-02-05 | 1994-03-10 | Board Of Regents, The University Of Texas System | Dietary supplements comprising vitamins and minerals |
CA2036695A1 (en) * | 1990-03-01 | 1991-09-02 | Brian Gregory Chapman | Solid imaging apparatus and method with coating station |
MC2246A1 (fr) * | 1990-04-03 | 1993-03-25 | Radopath Ltd | Utilisation de trinitrobenzenes ou d'acide carminique dans le traitement du cancer ou des maladies virales |
GB9103075D0 (en) * | 1991-02-13 | 1991-03-27 | Washington Odur Ayuko | Trinitrobenzene derivatives and their therapeutic use |
US5422277A (en) * | 1992-03-27 | 1995-06-06 | Ortho Diagnostic Systems Inc. | Cell fixative composition and method of staining cells without destroying the cell surface |
-
1994
- 1994-05-18 DZ DZ940047A patent/DZ1781A1/fr active
- 1994-05-20 AP APAP/P/1994/000647A patent/AP9400647A0/en unknown
- 1994-05-20 MA MA23512A patent/MA23202A1/fr unknown
- 1994-05-22 IL IL10971294A patent/IL109712A0/xx unknown
- 1994-05-23 BR BR9406548A patent/BR9406548A/pt not_active Application Discontinuation
- 1994-05-23 WO PCT/GB1994/001126 patent/WO1994027584A2/en not_active Application Discontinuation
- 1994-05-23 HU HU9503327A patent/HUT77764A/hu unknown
- 1994-05-23 EP EP94915671A patent/EP0700287A1/en not_active Ceased
- 1994-05-23 CN CN94192181A patent/CN1124012A/zh active Pending
- 1994-05-23 JP JP7500384A patent/JPH08510468A/ja active Pending
- 1994-05-23 CZ CZ953073A patent/CZ307395A3/cs unknown
- 1994-05-23 CA CA002163459A patent/CA2163459A1/en not_active Abandoned
- 1994-05-23 AU AU67297/94A patent/AU6729794A/en not_active Abandoned
- 1994-05-23 SK SK1457-95A patent/SK145795A3/sk unknown
-
1995
- 1995-11-21 NO NO954702A patent/NO954702L/no unknown
- 1995-11-21 OA OA60743A patent/OA10196A/en unknown
- 1995-11-21 FI FI955605A patent/FI955605A/fi not_active Application Discontinuation
- 1995-12-21 BG BG100242A patent/BG100242A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
HU9503327D0 (en) | 1996-01-29 |
AU6729794A (en) | 1994-12-20 |
IL109712A0 (en) | 1994-08-26 |
FI955605A (fi) | 1996-01-22 |
FI955605A0 (fi) | 1995-11-21 |
HUT77764A (hu) | 1998-08-28 |
JPH08510468A (ja) | 1996-11-05 |
WO1994027584A3 (en) | 1995-05-26 |
CN1124012A (zh) | 1996-06-05 |
SK145795A3 (en) | 1996-10-02 |
CA2163459A1 (en) | 1994-12-08 |
WO1994027584A2 (en) | 1994-12-08 |
AP9400647A0 (en) | 1995-11-20 |
OA10196A (en) | 1996-12-18 |
NO954702D0 (no) | 1995-11-21 |
MA23202A1 (fr) | 1994-12-31 |
BG100242A (bg) | 1996-07-31 |
DZ1781A1 (fr) | 2002-02-17 |
BR9406548A (pt) | 1996-01-02 |
EP0700287A1 (en) | 1996-03-13 |
CZ307395A3 (en) | 1996-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199901031A1 (ru) | Производные бензимидазола | |
BG103786A (bg) | Състав и метод за профилактика и лечение на нiv и други инфекциозни заболявания при човека | |
ATE141131T1 (de) | Fungizide wirkstoffkombinationen | |
RS50485B (sr) | Terapeutske kombinacije koje sadrže amplodipin i atorvastatin | |
ES2192201T3 (es) | Compuestos de piranona utiles para el tratamiento de infecciones retrovirales. | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
FI954989A (fi) | Lääkelaastari | |
BR9814323A (pt) | 4-hidroxiquinolina-3-carboxamidas e hidrazidas como agentes antiviróticos | |
DK0951473T3 (da) | Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette | |
HUP9904092A2 (hu) | Gyógyszerkészítmény HIV és rák kezelésére valamint eljárás előállítására | |
DK0973735T3 (da) | Polyaromatiske antivirale præparater | |
ATE165345T1 (de) | Sulfonsaeurederivate zur behandlung von viruserkrankungen | |
NO954702L (no) | Aryldannende medikamenter | |
BR0007514A (pt) | Macrolìdeos com atividade anti-inflamatória | |
ES2133412T3 (es) | 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma. | |
ATE215952T1 (de) | Hiv-proteaseinhibitoren | |
ATE212829T1 (de) | Feste, wasserfreie, pharmazeutische zubereitungen für vaginale verwendung | |
TR199900211T2 (xx) | Mupirosin ve klorheksidin'den olu�an bile�im. | |
TR199900661T2 (xx) | Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m� | |
DE58909850D1 (de) | Arzneimittel zur behandlung von krebs, aids und viruserkrankungen | |
EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
RU94040150A (ru) | Стабильная лиофилизированная композиция тиотепа, способ ее получения | |
DK178188A (da) | Antivirusmiddel | |
EA200000875A1 (ru) | Белки, взаимодействующие с каспазой-8 | |
DE69206913D1 (de) | Formulierungen zur Behandlung der vaginalen Trockenheit |